XOMA Corporation Cash Conversion Cycle 2011-2026 | XOMA

Annual Cash Conversion Cycle XOMA Corporation

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
23.6	18.2	-	-	2.26	-	-	-	-	-	-	-	-	-9.78 K	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
23.6	-9.78 K	-2.43 K

Quarterly Cash Conversion Cycle XOMA Corporation

2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
26.3	25.6	21.2	-	9.96	-	-	-	51.9	25	0.73	-	1.62	1.16	3.44	-	25.7	4.66	41.7	0.87	43.1	54	181	726	32.8	253	23.7	79.5	150	59.4	184	6.76	1	3.33	169	98.6	81.3	117	53.4	7.71	179	146	127	69.5	58.8	50.5	94.9	27.5	54.7	-41.7 K	-13.3 K	102	-12.5 K	-4.28 K	95.2	114	69.3	68.1	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
726	-41.7 K	-1.31 K

Cash Conversion Cycle of other stocks in the Biotechnology industry

Issuer	Cash Conversion Cycle	Price	% 24h	Market Cap	Country
Veracyte VCYT	32.2	$ 30.92	-5.73 %	$ 2.43 B	USA
Aeterna Zentaris AEZS	-34.3 K	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	186	-	-10.17 %	$ 12.2 K	USA
AIkido Pharma AIKI	17.9	-	1.93 %	$ 17.4 M	USA
I-Mab IMAB	-1.97 K	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	12.8	-	-	$ 40.3 B	USA
Albireo Pharma ALBO	-1.55 K	-	-0.23 %	$ 916 M	USA
Aptinyx APTX	46.9	-	-39.0 %	$ 4.57 M	USA
Midatech Pharma plc MTP	82.8	-	-18.52 %	$ 27.3 M	Britain
EyeGate Pharmaceuticals, Inc. EYEG	17	-	-1.52 %	$ 24.7 M	USA
Arena Pharmaceuticals ARNA	946	-	-6.81 %	$ 3.04 B	USA
Ayala Pharmaceuticals AYLA	-2.15 K	-	-	$ 7.46 M	Israel
Acorda Therapeutics ACOR	117	-	-24.86 %	$ 820 K	USA
bluebird bio BLUE	-54.4	-	-	$ 546 M	USA
Acasti Pharma ACST	1.97	-	4.01 %	$ 150 M	Canada
Институт стволовых клеток человека ISKJ	104	-	-	-	Russia
Avid Bioservices CDMO	85.5	-	-	$ 789 M	USA
Advaxis ADXS	-143 K	-	-9.65 %	$ 45.9 M	USA
Adaptive Biotechnologies Corporation ADPT	72.3	$ 12.67	-9.24 %	$ 1.92 B	USA
BeiGene, Ltd. BGNE	52.6	-	0.49 %	$ 251 B	Cayman-islands
Alnylam Pharmaceuticals ALNY	46.6	$ 321.51	-2.03 %	$ 42.1 B	USA
BioDelivery Sciences International BDSI	340	-	-4.8 %	$ 255 M	USA
Cara Therapeutics CARA	52.4	-	-3.03 %	$ 260 M	USA
ChemoCentryx CCXI	3.1	-	-	$ 3.74 B	USA
Enlivex Therapeutics Ltd. ENLV	-193	$ 1.09	-	$ 22.4 M	Israel
Equillium EQ	16.6	$ 1.91	-7.28 %	$ 109 M	USA
Amphastar Pharmaceuticals AMPH	205	$ 19.46	-0.36 %	$ 910 M	USA
Amarin Corporation plc AMRN	213	$ 14.23	-2.97 %	$ 5.91 B	Irlanda
CRISPR Therapeutics AG CRSP	1.1 K	$ 45.99	-3.28 %	$ 4.14 B	Schweiz
Arbutus Biopharma Corporation ABUS	50	$ 4.33	-2.81 %	$ 830 M	Canada
Brickell Biotech BBI	149	-	-5.38 %	$ 6.06 M	USA